Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening

Dan N. Tran, Benson Njuguna, Timothy Mercer, Imran Manji, Lydia Fischer, Marya Lieberman, Sonak D. Pastakia

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. Eighty percent of CVD deaths occur in low-income and middle-income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate health care systems that limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings so as to address these deficiencies.

Original languageEnglish (US)
Pages (from-to)125-134
Number of pages10
JournalCardiology Clinics
Volume35
Issue number1
DOIs
StatePublished - Feb 1 2017

Fingerprint

Cardiovascular Diseases
Health
Guidelines
Delivery of Health Care
Mortality
Therapeutics

Keywords

  • Accountability
  • Adherence
  • Availability
  • Cardiovascular disease medicines
  • Falsified and substandard medicines
  • Health-system strengthening
  • Low-income and middle-income countries
  • Patient-centered access

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening. / Tran, Dan N.; Njuguna, Benson; Mercer, Timothy; Manji, Imran; Fischer, Lydia; Lieberman, Marya; Pastakia, Sonak D.

In: Cardiology Clinics, Vol. 35, No. 1, 01.02.2017, p. 125-134.

Research output: Contribution to journalReview article

Tran, Dan N. ; Njuguna, Benson ; Mercer, Timothy ; Manji, Imran ; Fischer, Lydia ; Lieberman, Marya ; Pastakia, Sonak D. / Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening. In: Cardiology Clinics. 2017 ; Vol. 35, No. 1. pp. 125-134.
@article{e706ad65121d402d8ab0f9e910a98448,
title = "Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening",
abstract = "Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. Eighty percent of CVD deaths occur in low-income and middle-income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate health care systems that limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings so as to address these deficiencies.",
keywords = "Accountability, Adherence, Availability, Cardiovascular disease medicines, Falsified and substandard medicines, Health-system strengthening, Low-income and middle-income countries, Patient-centered access",
author = "Tran, {Dan N.} and Benson Njuguna and Timothy Mercer and Imran Manji and Lydia Fischer and Marya Lieberman and Pastakia, {Sonak D.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.ccl.2016.08.008",
language = "English (US)",
volume = "35",
pages = "125--134",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening

AU - Tran, Dan N.

AU - Njuguna, Benson

AU - Mercer, Timothy

AU - Manji, Imran

AU - Fischer, Lydia

AU - Lieberman, Marya

AU - Pastakia, Sonak D.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. Eighty percent of CVD deaths occur in low-income and middle-income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate health care systems that limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings so as to address these deficiencies.

AB - Cardiovascular disease (CVD) is the leading cause of global mortality and is expected to reach 23 million deaths by 2030. Eighty percent of CVD deaths occur in low-income and middle-income countries (LMICs). Although CVD prevention and treatment guidelines are available, translating these into practice is hampered in LMICs by inadequate health care systems that limit access to lifesaving medications. In this review article, we describe the deficiencies in the current LMIC supply chains that limit access to effective CVD medicines, and discuss existing solutions that are translatable to similar settings so as to address these deficiencies.

KW - Accountability

KW - Adherence

KW - Availability

KW - Cardiovascular disease medicines

KW - Falsified and substandard medicines

KW - Health-system strengthening

KW - Low-income and middle-income countries

KW - Patient-centered access

UR - http://www.scopus.com/inward/record.url?scp=84996805823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996805823&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2016.08.008

DO - 10.1016/j.ccl.2016.08.008

M3 - Review article

C2 - 27886782

AN - SCOPUS:84996805823

VL - 35

SP - 125

EP - 134

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

IS - 1

ER -